Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) — The “Asia-Pacific Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology, Application, Country, and Segment Forecasts, 2025-2030” report has been added to ResearchAndMarkets.com’s offering.
The Asia Pacific radiation oncology market size is expected to reach USD 4.02 billion in 2030 and is projected to grow at a CAGR of 11.6% from 2025 to 2030. Technological advancements in radiation therapy over the years is one of the key factors responsible for market growth.
Advancements in computers have resulted in faster, smarter, and more capable treatment planning and have enabled constant imaging guidance, more precise dosing, and delivery of higher doses. This has resulted in greater efficiency and lesser adverse effects. In addition, major key players are increasingly focusing on the development and launch of new and innovative brachytherapy products.
Furthermore, rising strategic initiatives by hospitals and key players to adopt new technologies are expected to boost market growth. In addition, increasing approval by regulatory bodies to enhance access to advanced radiation therapy for patients and clinicians is anticipated to drive the market.
The rising installation of new radiotherapy systems in hospitals by manufacturers is anticipated to accelerate market growth. An increasing number of proton centers to combat the rising demand for accurate and effective radiation therapy technologies is anticipated to boost the market over the forecast period.
Elekta AB and Accuray Incorporated are expected to hold a majority of share in the market over the forecast period. Elekta AB is geographically expanding in markets outside China and an increasing number of installed units are expected to reach the end of the life cycle, further requiring replacements, service, and support. Furthermore, Accuray Incorporated is focusing on strategic collaborations to attain a high market share.
Asia Pacific Radiation Oncology Market Report Highlights
- External beam radiation therapy (EBRT) dominated the market with a revenue share of 35.9% in 2024.
- Internal beam radiation therapy is expected to grow at the fastest CAGR of 16.5% over the forecast period.
- Applications in breast cancer under the EBRT segment led the market with 26.3% of the total revenue share in 2024, driven by EBRT’s effectiveness, increased awareness, and early detection initiatives.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
- Competitive Landscape: Explore the market presence of key players worldwide
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
The leading players in the Asia-Pacific Radiation Oncology market include:
- NTP Radioisotopes SOC Ltd
- Varian Medical Systems, Inc.
- Nordion Inc.
- Mevion Medical Systems
- Perspecitve Therapeutics Inc.
- Accuray Incorporated
- BD
- IBA Radiopharma Solutions
- Elekta
- Curium
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 90 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $2.13 Billion |
| Forecasted Market Value (USD) by 2030 | $4.02 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Asia Pacific |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Asia Pacific Radiation Oncology Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.3. Business Environment Analysis
Chapter 4. Asia Pacific Radiation Oncology Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. External Beam Radiation Therapy
4.4.3. MRI LINACs
4.4.4. Compact Advanced Radiotherapy Systems
4.4.4.1. Compact Advanced Radiotherapy Systems Market, 2018 – 2030 (USD Million)
4.4.4.2. Cyberknife
4.4.4.3. Gamma Knife
4.4.4.4. Tomotherapy
4.4.5. Proton Therapy
4.4.5.1. Proton Therapy Market, 2018 – 2030 (USD Million)
4.4.5.2. Cyclotron
4.4.5.3. Synchrotron
4.5. Internal Beam Radiation Therapy
4.5.2. Brachytherapy
4.5.3. Systemic Beam Radiation Therapy
4.5.4. Others
Chapter 5. Asia Pacific Radiation Oncology Market: Technology Business Analysis
5.1. Technology Market Share, 2024 & 2030
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. External Beam Radiation Therapy
5.4.1. External Beam Radiation Therapy Market, 2018 – 2030 (USD Million)
5.4.2. Image-Guided Radiotherapy (IGRT)
5.4.3. Intensity Modulated Radiotherapy (IMRT)
5.4.4. Stereotactic Technology
5.4.5. Proton Beam Therapy
5.4.6. 3D Conformal Radiotherapy (3D CRT)
5.4.7. Volumetric Modulated Arc Therapy (VMAT)
5.5. Brachytherapy
5.5.1. Brachytherapy Market, 2018 – 2030 (USD Million)
5.5.2. HDR Brachytherapy
5.5.3. LDR Brachytherapy
Chapter 6. Asia Pacific Radiation Oncology Market: Application Business Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. External Beam Radiation Therapy
6.4.1. External Beam Radiation Therapy Market, 2018 – 2030 (USD Million)
6.4.2. Prostate Cancer
6.4.3. Breast Cancer
6.4.4. Lung Cancer
6.4.5. Head and Neck Cancer
6.4.6. Colorectal Cancer
6.4.7. Others
6.5. Internal Beam Radiation Therapy
6.5.1. Internal Beam Radiation Therapy Market, 2018 – 2030 (USD Million)
6.5.2. Prostate Cancer
6.5.3. Gynecological Cancer
6.5.4. Breast Cancer
6.5.5. Cervical Cancer
6.5.6. Penile Cancer
Chapter 7. Asia Pacific Radiation Oncology Market: Country Estimates & Trend Analysis by Type, Technology, and Application
7.1. Country Market Share Analysis, 2024 & 2030
7.2. Country Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- NTP Radioisotopes SOC
- Varian Medical Systems
- Nordion
- Mevion Medical Systems
- Perspecitve Therapeutics
- Accuray Incorporated
- BD
- IBA Radiopharma Solutions
- Elekta
- Curium
For more information about this report visit https://www.researchandmarkets.com/r/n8oqb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Asia-Pacific Radiation Oncology Market
